DK165988C - Modificerede egliner b og c, deres anvendelse som proteaseinhibitorer, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende de modificerede egliner b og c - Google Patents
Modificerede egliner b og c, deres anvendelse som proteaseinhibitorer, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende de modificerede egliner b og cInfo
- Publication number
- DK165988C DK165988C DK332684A DK332684A DK165988C DK 165988 C DK165988 C DK 165988C DK 332684 A DK332684 A DK 332684A DK 332684 A DK332684 A DK 332684A DK 165988 C DK165988 C DK 165988C
- Authority
- DK
- Denmark
- Prior art keywords
- modified
- eglines
- procedures
- preparing
- pharmaceutical preparations
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Pain & Pain Management (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Paper (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3324534 | 1983-07-07 | ||
DE3324534A DE3324534A1 (de) | 1983-07-07 | 1983-07-07 | Modifizierte protease-inhibitoren, verfahren zu ihrer herstellung und daraus bereitete pharmazeutische mittel |
Publications (4)
Publication Number | Publication Date |
---|---|
DK332684D0 DK332684D0 (da) | 1984-07-06 |
DK332684A DK332684A (da) | 1985-01-08 |
DK165988B DK165988B (da) | 1993-02-22 |
DK165988C true DK165988C (da) | 1993-07-26 |
Family
ID=6203414
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK332684A DK165988C (da) | 1983-07-07 | 1984-07-06 | Modificerede egliner b og c, deres anvendelse som proteaseinhibitorer, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende de modificerede egliner b og c |
Country Status (10)
Country | Link |
---|---|
US (1) | US4636489A (da) |
EP (1) | EP0134479B1 (da) |
JP (1) | JPH0670077B2 (da) |
AT (1) | ATE32728T1 (da) |
CA (1) | CA1230069A (da) |
DE (2) | DE3324534A1 (da) |
DK (1) | DK165988C (da) |
ES (1) | ES8601108A1 (da) |
GR (1) | GR82243B (da) |
IE (1) | IE57698B1 (da) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6342373B1 (en) * | 1983-11-21 | 2002-01-29 | Ucp Gen-Pharma Ag | Process for preparing recombinant eglin, protease inhibitor |
DE3506992A1 (de) * | 1985-02-27 | 1986-08-28 | Plantorgan Werk Heinrich G.E. Christensen, KG, 2903 Bad Zwischenahn | Modifizierte hirudine, verfahren zu deren herstellung und pharmazeutische mittel, die diese wirkstoffe enthalten |
US5166134A (en) * | 1986-12-24 | 1992-11-24 | John Lezdey | Treatment of allergic rhinitis |
ES2063161T3 (es) * | 1988-03-07 | 1995-01-01 | Ciba Geigy Ag | Proteinas modificadas. |
US5180667A (en) * | 1988-03-07 | 1993-01-19 | Ciba-Geigy Corporation | Genes encoding eglin C mutants |
US5114921A (en) * | 1988-05-27 | 1992-05-19 | The Children's Hospital Of Philadelphia | Amphiphilic peptides and use thereof |
EP0416035B1 (en) * | 1988-05-27 | 1994-12-07 | The Children's Hospital Of Philadelphia | Amphiphilic peptides and use thereof |
DE58907266T2 (de) * | 1988-06-11 | 1994-09-29 | Ciba Geigy Ag | Polypeptide mit einer die Koagulierung hemmenden Wirkung. |
US5268296A (en) * | 1988-06-11 | 1993-12-07 | Ciba-Geigy Corporation | DNA vector and recombinant host cell for production of hirullin P6 and P18 |
US5254535A (en) * | 1989-04-17 | 1993-10-19 | The Children's Hospital Of Pennsylvania | Composition and treatment with biologically active peptides and antibiotic |
US5459237A (en) * | 1990-02-08 | 1995-10-17 | Magainin Pharmaceuticals Inc. | Peptide compositions and uses therefor |
US5792831A (en) * | 1990-02-08 | 1998-08-11 | Magainin Pharmaceuticals Inc. | Analogues of magainin peptides containing D-amino acids |
EP0514464A4 (en) * | 1990-02-08 | 1993-04-28 | Magainin Sciences, Inc. | Biologically active amphiphilic peptides and method of inhibiting growth of target cells, virus or virally-infected cell |
WO1991017760A1 (en) * | 1990-05-14 | 1991-11-28 | Magainin Sciences Inc. | Composition of and treatment with biologically active peptides having d-amino acid residues |
US5208220A (en) * | 1990-06-27 | 1993-05-04 | Magainin Pharmaceuticals, Inc. | Composition and treatment with biologically active peptides and antibiotics which inhibit DNA gyrase |
EP0559647A1 (en) * | 1990-06-27 | 1993-09-15 | Magainin Pharmaceuticals Inc. | Composition and treatment with biologically active peptides and antibiotics which inhibit dna gyrase |
DK0587799T3 (da) * | 1991-05-23 | 1999-11-22 | Merrell Pharma Inc | Inhibitorer af cathepsin G og elastase til forebyggelse af bindevævsnedbrydning |
US5714470A (en) | 1991-08-22 | 1998-02-03 | Merrell Pharmaceuticals, Inc. | Orally-active elastase inhibitors |
US5478811A (en) * | 1991-08-22 | 1995-12-26 | Merrell Dow Pharmaceuticals Inc. | Orally-active elastase inhibitors |
CA2120337A1 (en) * | 1991-10-16 | 1993-04-17 | Michael A. Zasloff | Composition and treatment with biologically active peptides and antibiotic |
ATE206055T1 (de) * | 1994-06-02 | 2001-10-15 | Merrell Pharma Inc | Acylierte enolderivate als vorläufdrogen von elastaseinhibitoren |
DE69513167T2 (de) * | 1994-06-02 | 2000-06-15 | Merrell Pharmaceuticals Inc., Cincinnati | Perfluoroalkyll ketone, inhibitoren von elastase und prozess zur deren herstellung |
US6172044B1 (en) | 1995-12-01 | 2001-01-09 | Aventis Pharmaceuticals Inc. | Acylated enol derivative of α-ketoesters and α-ketoamides |
US5948886A (en) * | 1996-11-20 | 1999-09-07 | Hoechst Marion Roussel, Inc. | Acylated enol derivatives of α-ketoesters and α-ketoamides |
CA2266323A1 (en) | 1996-09-24 | 1998-04-02 | The Procter & Gamble Company | Stabilized proteinaceous protease inhibitors and variants thereof |
US7001884B2 (en) * | 2001-06-18 | 2006-02-21 | Regents Of The University Of Michigan | Eglin c based drugs for treatment of disease |
DE102005007313A1 (de) * | 2005-02-17 | 2006-08-24 | Wacker Chemie Ag | Verfahren zur Herstellung von Entschäumerformulierungen |
KR101237116B1 (ko) * | 2010-11-12 | 2013-02-25 | 대한유화공업 주식회사 | 내충격성 및 내압특성이 우수한 폴리프로필렌 조성물 |
CN110551707A (zh) * | 2019-10-17 | 2019-12-10 | 山西大学 | 一种纯化中性或碱性蛋白酶的方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2808396C2 (de) * | 1978-02-27 | 1984-04-19 | Plantorgan Werk Heinrich G.E. Christensen, KG, 2903 Bad Zwischenahn | Protease-Inhibitoren |
US4250086A (en) * | 1979-11-19 | 1981-02-10 | Ortho Pharmaceutical Corporation | Method and composition for preparation of H-SAR-LYS-SAR-GLN-NH2 |
-
1983
- 1983-07-07 DE DE3324534A patent/DE3324534A1/de not_active Withdrawn
-
1984
- 1984-07-05 EP EP84107861A patent/EP0134479B1/de not_active Expired
- 1984-07-05 CA CA000458165A patent/CA1230069A/en not_active Expired
- 1984-07-05 AT AT84107861T patent/ATE32728T1/de not_active IP Right Cessation
- 1984-07-05 DE DE8484107861T patent/DE3469534D1/de not_active Expired
- 1984-07-06 ES ES534098A patent/ES8601108A1/es not_active Expired
- 1984-07-06 IE IE1734/84A patent/IE57698B1/en not_active IP Right Cessation
- 1984-07-06 GR GR75233A patent/GR82243B/el unknown
- 1984-07-06 JP JP59139198A patent/JPH0670077B2/ja not_active Expired - Lifetime
- 1984-07-06 US US06/628,355 patent/US4636489A/en not_active Expired - Fee Related
- 1984-07-06 DK DK332684A patent/DK165988C/da active
Also Published As
Publication number | Publication date |
---|---|
EP0134479A1 (de) | 1985-03-20 |
GR82243B (da) | 1984-12-13 |
DE3469534D1 (en) | 1988-04-07 |
DK332684A (da) | 1985-01-08 |
DK165988B (da) | 1993-02-22 |
CA1230069A (en) | 1987-12-08 |
EP0134479B1 (de) | 1988-03-02 |
US4636489A (en) | 1987-01-13 |
IE57698B1 (en) | 1993-03-10 |
IE841734L (en) | 1985-01-07 |
DK332684D0 (da) | 1984-07-06 |
DE3324534A1 (de) | 1985-01-17 |
ES534098A0 (es) | 1985-10-16 |
JPS60105699A (ja) | 1985-06-11 |
ES8601108A1 (es) | 1985-10-16 |
ATE32728T1 (de) | 1988-03-15 |
JPH0670077B2 (ja) | 1994-09-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK165988C (da) | Modificerede egliner b og c, deres anvendelse som proteaseinhibitorer, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende de modificerede egliner b og c | |
DK160614C (da) | Analogifremgangsmaade til fremstilling af vinblastinderivater og farmaceutisk acceptable salte deraf | |
DK0548114T5 (da) | Mometason-furoat-monohydrat, fremgangsmåde til fremtilling deraf og farmaceutiske præparater indeholdende dette | |
DK552684D0 (da) | Desulfatohirudiner samt deres fremstilling og anvendelse | |
DK573384A (da) | Sphingosinderivater, fremgangsmaade til deres fremstilling og farmaceutiske kompositioner indeholdende disse derivater | |
DK81583D0 (da) | Derivater af 3-hydroxysmoersyre og fremgangsmade til fremstilling deraf | |
DK130683D0 (da) | Derivater af bicycliske aminosyrer, fremgangsmader til fremstilling deraf, midler indeholdende disse forbindelser og deres anvendelse samt bicycliske aminosyrer som mellemprodukter og fremgangsmade til fremstilling heraf | |
DK93685D0 (da) | Benzisoselenazolthioner, fremgangsmaade til fremstilling af disse forbindelser og farmaceutiske praeparater indeholdende disse forbindelser | |
DK222688D0 (da) | Vaesker til konditionering af tand- og knoglestoffer, deres fremstilling og anvendelse | |
DK1089968T3 (da) | Thyroideahormonanaloger og fremgangsmåder til deres fremstilling | |
DK11187D0 (da) | Dna-sekvenser der koder for proteiner med husi-type i inhibitorers biologiske aktivitet, biotekniske fremgangsmaader til fremstilling af proteinerne o g farmaceutiske praeparater der indeholder dem | |
DK0658585T3 (da) | Amidinophenylalaninderivater, fremgangsmåde til deres fremstilling, deres anvendelse og midler indeholdende disse som antik | |
DK494684D0 (da) | Benzensulfonyl-lactamer, fremgangsmaade til deres fremstilling og deres anvendelse som aktiv komponent i framaceutiske kompositioner | |
DK274980A (da) | 1-alkadien-2,4-yl-2-hydroxymethyl-3,4,5-trihydroxypiperidiner fremgangsmaade til fremstilling heraf samt deres anvendelse som laegemidler | |
NO821841L (no) | Mettede aminocyklitderivater, deres fremstilling og legemiddel inneholdende dem | |
DK52080A (da) | Dehydropeptider fremgangsmaader til deres fremstilling samt deres anvendelse som laegemidler | |
DK319384D0 (da) | 1-0-alkyl-3-amino-propan-1,2-diol-2-0-phospholipider, fremgangsmaade til deres fremstilling samt farmaceutiske praeparater indeholdende disse | |
DK630088D0 (da) | Azelastinembonat, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater med indhold af denne forbindelse som aktivt middel | |
DE3162674D1 (en) | A purified polypeptide, a process for its preparation, its use and pharmaceutical compositions containing it | |
DK209284D0 (da) | Dihydropyridiner,farmaceutiske kompositioner indeholdende disse,fremgangsmaade til forbindelsernes fremstilling og mellemprodukter anvendelige ved denne fremgangsmaade | |
JPS51136602A (en) | Process for preparation of amino acid or peptide |